Aravive (NASDAQ: ARAV) stock is up 27% premarket. This looks very hopeful to us in ARAV stock - we think it likely that this will face away. There is always the option that someone is about to ride ...

Now this isn’t entirely and wholly true, there may be other cancers it works on and so on but the specific target they were testing for, nope, doesn’t work. From Aravive: “ Aravive, Inc. (Nasdaq: ARAV ...

Aravive (ARAV) delivered earnings and revenue surprises of -39.39% and 298.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

WESTFORD — U.S. Rep. Lori Trahan announced that Westford eighth graders Arav Jain and Som Lunavat are winners of the Third Congressional District’s annual Congressional App Challenge. The two… ...